Statistics

Total Visits

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study32

Select a period of time:

Number of views in the range

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study17

Views

Views
October 20241
November 20240
December 20240
January 20250
February 20250
March 202516
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Spain1
 

Top cities views

Views